Compuestos de piridazina, composiciones y métodos

Un compuesto de fórmula II:**Fórmula** en la que R10 y R11 son independientemente hidrógeno, hidroxilo, alquilo, alquenilo, alquinilo, alquileno, alquenileno,alcoxi, alqueniloxi, cicloalquilo, cicloalquenilo, arilo, ariloxi, arilalcoxi, aroilo, heteroarilo, heterociclo, acilo, aciloxi,sulfonilo, sul...

Full description

Saved in:
Bibliographic Details
Main Authors HAIECH, JACQUES, VELENTZA, ANASTASIA, HIBERT, MARCEL, ZASADZKI, MAGDELENA, BOURGUIGNON, JEAN-JACQUES, HU, WENHUI, VAN ELDIK, LINDA, WATTERSON, D. MARTIN
Format Patent
LanguageSpanish
Published 06.02.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Un compuesto de fórmula II:**Fórmula** en la que R10 y R11 son independientemente hidrógeno, hidroxilo, alquilo, alquenilo, alquinilo, alquileno, alquenileno,alcoxi, alqueniloxi, cicloalquilo, cicloalquenilo, arilo, ariloxi, arilalcoxi, aroilo, heteroarilo, heterociclo, acilo, aciloxi,sulfonilo, sulfinilo, sulfenilo, amino, imino, azido, tiol, tioalquilo, tioalcoxi, tioarilo, nitro, ureido, ciano, halo, sililo,sililoxi, sililalquilo, sililtio, >=O, >=S, carboxilo, carbonilo, carbamoilo o carboxamida; o una sal farmacéuticamenteaceptable del mismo. The invention relates to novel chemical compounds, compositions and methods of making and using the same. In particular, the invention provides pyridazine compounds and/or related heterocyclic derivatives, compositions comprising the same, and methods of making and using pyridazine compounds and/or related heterocyclic derivatives and compositions comprising the same, for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications. Compounds of Formula Ia or Ib or wherein R is a substituted amino group, R 2 is an unsaturated 5 to 6-membered heteromonocyclic group containing 1 to 4 nitrogen atoms, R 3 , R 4 , R 5 , and R 6 are hydrogen, and R 7 is absent; or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: ES20050817588T